Patent · US Active

Synthetic apelin mimetics for the treatment of heart failure

US9982017B2 · kind B2 · utility

3Cited by

16References

17Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Frederic Zecri · Cambridge, US
Andrei Golosov · Cambridge, US
Philipp Grosche · Inzlingen, DE
Hongjuan Zhao · Lexington, US
Qi Hu · Needham, US
Hidetomo Imase · Somerville, US

Key dates

Filing date	May 18, 2015
Grant date	May 29, 2018
Priority date	—
Expiry date	Dec 19, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2205/502
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a synthetic polypeptide of Formula I′:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.